source
- Lycia Therapeutics targets $228M IPO to fund food allergy protein degrader programsLycia Therapeutics announced plans for an initial public offering expected to raise about $228 million. The proceeds are intended to support its pipeline of protein degrader therapeutics targeting…
- Proposed ACGME rule changes could strip resident doctors of mandatory rest periodsArifeen Rahman, a clinical instructor in rhinology at the Medical University of South Carolina, recounts working 90-hour weeks as a junior otolaryngology resident in 2023, often exceeding the ACGME…